Delineation of the functional properties and the mechanism of action of AA29504, an allosteric agonist and positive allosteric modulator of GABAA receptors

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Biochemical Pharmacology

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.bcp.2018.02.015PMID 29454619
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Binding.

  2021cited by this paper
• Functional properties and mechanism of action of PPTQ, an allosteric agonist and low nanomolar positive allosteric modulator at GABAA receptors

  2018cited by this paper
• GABAA Receptors and the Diversity in their Structure and Pharmacology.

  2017cited by this paper
• Development of a Robust Mammalian Cell‐based Assay for Studying Recombinant α4β1/3δ GABAA Receptor Subtypes

  2017cited by this paper
• GABAA receptor subtype involvement in addictive behaviour

  2017cited by this paper
• Molecular tools for GABAA receptors: High affinity ligands for β1-containing subtypes

  2017cited by this paper
• Kavain, the Major Constituent of the Anxiolytic Kava Extract, Potentiates GABAA Receptors: Functional Characteristics and Molecular Mechanism

  2016cited by this paper
• A pharmacological assessment of agonists and modulators at α4β2γ2 and α4β2δ GABAA receptors: The challenge in comparing apples with oranges.

  2016cited by this paper
• Toward Understanding Functional Properties and Subunit Arrangement of α4β2δ γ-Aminobutyric Acid, Type A (GABAA) Receptors*

  2016cited by this paper
• High and low GABA sensitivity α4β2δ GABAA receptors are expressed in Xenopus laevis oocytes with divergent stoichiometries.

  2016cited by this paper
• Functional sites involved in modulation of the GABAA receptor channel by the intravenous anesthetics propofol, etomidate and pentobarbital.

  2016cited by this paper
• A Multifaceted GABAA Receptor Modulator: Functional Properties and Mechanism of Action of the Sedative-Hypnotic and Recreational Drug Methaqualone (Quaalude)

  2015influential reference
• Allosteric modulation of GABAA receptors via multiple drug-binding sites.

  2015cited by this paper
• Identification of the putative binding pocket of valerenic acid on GABAA receptors using docking studies and site‐directed mutagenesis

  2015cited by this paper
• The GABAA Receptor as a Therapeutic Target for Neurodevelopmental Disorders.

  2015cited by this paper
• Functional Characterization of the 1,5-Benzodiazepine Clobazam and Its Major Active Metabolite N-Desmethylclobazam at Human GABAA Receptors Expressed in Xenopus laevis Oocytes

  2015cited by this paper
• Allosteric ligands and their binding sites define γ-aminobutyric acid (GABA) type A receptor subtypes.

  2015cited by this paper
• Probing α4βδ GABAA Receptor Heterogeneity: Differential Regional Effects of a Functionally Selective α4β1δ/α4β3δ Receptor Agonist on Tonic and Phasic Inhibition in Rat Brain

  2014cited by this paper
• Crystal structure of a human GABAA receptor

  2014cited by this paper
• Mutations at Beta N265 in γ-Aminobutyric Acid Type A Receptors Alter Both Binding Affinity and Efficacy of Potent Anesthetics

  2014cited by this paper
• GABAA receptor subtypes: Therapeutic potential in Down syndrome, affective disorders, schizophrenia, and autism.

  2014cited by this paper
• Cysteine Substitutions Define Etomidate Binding and Gating Linkages in the α-M1 Domain of γ-Aminobutyric Acid Type A (GABAA) Receptors*

  2013cited by this paper
• Subtype selectivity of α+β− site ligands of GABAA receptors: identification of the first highly specific positive modulators at α6β2/3γ2 receptors

  2013cited by this paper
• Potency of GABA at human recombinant GABAA receptors expressed in Xenopus oocytes: a mini review

  2013influential reference
• Extrasynaptic GABA(A) receptors: their function in the CNS and implications for disease.

  2012cited by this paper
• Positive modulation of δ-subunit containing GABA(A) receptors in mouse neurons.

  2012influential reference
• Mapping general anesthetic binding site(s) in human α1β3 γ-aminobutyric acid type A receptors with [³H]TDBzl-etomidate, a photoreactive etomidate analogue.

  2012cited by this paper
• Extrasynaptic GABAA receptor activation reverses recognition memory deficits in an animal model of schizophrenia

  2011cited by this paper
• The GABAA Receptor α+β− Interface: A Novel Target for Subtype Selective Drugs

  2011influential reference
• GABAA receptor subtype-selective modulators. I. α2/α3-selective agonists as non-sedating anxiolytics.

  2011cited by this paper
• GABAA receptor subtype-selective modulators. II. α5-selective inverse agonists for cognition enhancement.

  2011cited by this paper
• Ginkgolide X Is a Potent Antagonist of Anionic Cys-loop Receptors with a Unique Selectivity Profile at Glycine Receptors*

  2010cited by this paper
• Pharmacological characterization of a novel positive modulator at alpha 4 beta 3 delta-containing extrasynaptic GABA(A) receptors.

  2010influential reference
• Binding, activation and modulation of Cys-loop receptors.

  2010cited by this paper
• Novel compounds selectively enhance delta subunit containing GABA A receptors and increase tonic currents in thalamus.

  2009cited by this paper
• γ-Amino Butyric Acid Type A Receptor Mutations at β2N265 Alter Etomidate Efficacy While Preserving Basal and Agonist-dependent Activity

  2009cited by this paper
• Structure of α6β3δ GABAA receptors and their lack of ethanol sensitivity

  2009cited by this paper
• Tryptophan Mutations at Azi-Etomidate Photo-Incorporation Sites on α1 or β2 Subunits Enhance GABAA Receptor Gating and Reduce Etomidate Modulation

  2008cited by this paper
• The expression of GABAAβ subunit isoforms in synaptic and extrasynaptic receptor populations of mouse dentate gyrus granule cells

  2008cited by this paper
• International Union of Pharmacology. LXX. Subtypes of γ-Aminobutyric AcidA Receptors: Classification on the Basis of Subunit Composition, Pharmacology, and Function. Update

  2008cited by this paper
• Valerenic acid potentiates and inhibits GABA(A) receptors: molecular mechanism and subunit specificity.

  2007cited by this paper
• Pharmacological Characterization of Agonists at δ-Containing GABAA Receptors: Functional Selectivity for Extrasynaptic Receptors Is Dependent on the Absence of γ2

  2006cited by this paper
• Treating insomnia: Current and investigational pharmacological approaches.

  2006cited by this paper
• Pharmacological characterization of agonists at delta-containing GABAA receptors: Functional selectivity for extrasynaptic receptors is dependent on the absence of gamma2.

  2006cited by this paper
• Identification of a GABAA Receptor Anesthetic Binding Site at Subunit Interfaces by Photolabeling with an Etomidate Analog

  2006cited by this paper
• Extrasynaptic GABAA Receptors of Thalamocortical Neurons: A Molecular Target for Hypnotics

  2005cited by this paper
• Variations on an inhibitory theme: phasic and tonic activation of GABAA receptors

  2005cited by this paper
• Defining the propofol binding site location on the GABAA receptor.

  2004cited by this paper
• The modulatory action of loreclezole at the y-aminobutyric acid type A receptor is determined by a single amino acid in the P 2 and f 3 subunit

  2004cited by this paper
• Salicylidene salicylhydrazide, a selective inhibitor of β1‐containing GABAA receptors

  2004cited by this paper
• Fluticasone propionate

  2003cited by this paper
• Molecular determinants for the action of general anesthetics 
at recombinant α2β3γ2γ‐aminobutyric acidA receptors

  2002cited by this paper
• Methionine 286 in transmembrane domain 3 of the GABAA receptor beta subunit controls a binding cavity for propofol and other alkylphenol general anesthetics.

  2001cited by this paper
• Subunit‐selective modulation of GABAA receptors by the non‐steroidal anti‐inflammatory agent, mefenamic acid

  1999cited by this paper
• Propofol and other intravenous anesthetics have sites of action on the gamma-aminobutyric acid type A receptor distinct from that for isoflurane.

  1998cited by this paper
• The interaction of general anaesthetics with recombinant GABAA and glycine receptors expressed in Xenopus laevis oocytes: a comparative study

  1997cited by this paper
• The interaction of the general anesthetic etomidate with the gamma-aminobutyric acid type A receptor is influenced by a single amino acid.

  1997cited by this paper
• Subunit‐dependent interaction of the general anaesthetic etomidate with the γ‐aminobutyric acid type A receptor

  1997cited by this paper
• The modulatory action of loreclezole at the gamma-aminobutyric acid type A receptor is determined by a single amino acid in the beta 2 and beta 3 subunit.

  1994cited by this paper
• A novel allosteric modulatory site on the GABAA receptor β subunit

  1994cited by this paper
• A novel allosteric modulatory site on the GABAA receptor beta subunit.

  1994cited by this paper

• Recent advances in GABAA receptor targeting ligands.

  2026cites this paper
• Molecular Determinants Underlying Delta Selective Compound 2 Activity at δ-Containing GABAA Receptors

  2021influential citation
• Molecular determinants underlying DS2 activity at δ-containing GABAA receptors

  2021cites this paper
• The Influence of AA29504 on GABAA Receptor Ligand Binding Properties and Its Implications on Subtype Selectivity

  2021cites this paper
• GABAkines - Advances in the discovery, development, and commercialization of positive allosteric modulators of GABAA receptors.

  2021cites this paper
• From Methaqualone and Beyond: Structure-Activity Relationship of 6-, 7-, and 8-Substituted 2,3-Diphenyl-quinazolin-4(3H)-ones and in Silico Prediction of Putative Binding Modes of Quinazolin-4(3H)-ones as Positive Allosteric Modulators of GABAA Receptors.

  2020cites this paper
• Alcohol-Responsive Hyperkinetic Movement Disorders—a Mechanistic Hypothesis

  2020cites this paper
• The effects of a competitive antagonist on GABA-evoked currents in the presence of sedative-hypnotic agents

  2020cites this paper